Announcements Trials
Browse Landscape

Phase

Phase 4 6Phase NA 5Phase 2 5Phase 3 4Phase EARLY_PHASE1 1Phase 1 1

Status

Completed 3Unknown 1

Sponsor Class

OTHER 4INDUSTRY 2

Study Type

Interventional 4

Sponsor

Cancer Type

Breast 2Other 1Head & Neck 1

Conditions

Pain 1Neoplasms 1Mucositis 1Inflammation 1Head and Neck Neoplasms 1Cachexia 1Breast Neoplasms 1Breast Diseases 1Agnosia 1Abnormalities, Radiation-Induced 1

Interventions

Cisplatin 294Radiotherapy 230Fluorouracil 201Cyclophosphamide 191Capecitabine 183Docetaxel 167Gemcitabine 165Oxaliplatin 162Carboplatin 161Paclitaxel 152Leucovorin 122Drug Therapy 119Dexamethasone 119Doxorubicin 112Etoposide 99Bevacizumab 91Cytarabine 87Vincristine 83Irinotecan 81Rituximab 77Epirubicin 71Prednisone 65Radiosurgery 63Methotrexate 62Surgical Procedures, Operative 61Radiation 60Radiotherapy, Intensity-Modulated 57Neoadjuvant Therapy 53Lenalidomide 52Letrozole 51

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 3 × OTHER × Ibuprofen × Clear all
NCT02330926 2025-08-29

MENAC

Norwegian University of Science and Technology

Phase 3 Completed
221 enrolled

Cachexia, Neoplasms

NCT02480114 2021-02-18

Gabapentin Compared to Standard of Care in Preventing Mucositis in Patients With Stage III-IV Head and Neck Cancer Undergoing Primary or Adjuvant Chemoradiation Therapy

Vanderbilt-Ingram Cancer Center

Phase 3 Completed
79 enrolled 8 charts
Head & NeckOther

Abnormalities, Radiation-Induced, Head and Neck Neoplasms, Mucositis

NCT02141139 2014-05-19

Perioperative Inflammation and Breast Cancer Outcome

Samsung Medical Center

Phase 3 Unknown
1,568 enrolled
Breast

Breast Neoplasms, Inflammation

NCT00299039 2009-02-02

T3AI

Nova Scotia Health Authority

Phase 3 Completed
150 enrolled
Breast

Agnosia, Breast Diseases, Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡